Park West Asset Management LLC Ironwood Pharmaceuticals Inc Transaction History

Park West Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $11.3 Million - $14.6 Million	-1,112,383 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $1.44 Million - $1.89 Million	159,192 Added 16.7%	1,112,383 $12.4 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $8.63 Million - $11.6 Million	953,191 New	953,191 $10.9 Million
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $9.32 Million - $19.3 Million	-1,194,945 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $5.54 Million - $6.83 Million	387,004 Added 47.9%	1,194,945 $22.1 Million
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $2.1 Million - $2.87 Million	177,348 Added 28.12%	807,941 $15.4 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $185,147 - $226,735	16,635 Added 2.71%	630,593 $9.73 Million
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $7.47 Million - $8.95 Million	613,958	613,958 $9.2 Million

245

163M

11.5M

12.9K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $224M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Park West Asset Management LLC with notifications on news.